TERT promoter mutations and gene amplification: Promoting TERT expression in Merkel cell carcinoma

Telomerase activation through the induction of its catalytic component TERT is essential in carcinogenesis. The regulatory mechanism and clinical significance underlying cancer-specific TERT expression have been extensively investigated in various human malignancies, but little is known about these in Merkel cell carcinoma (MCC), an aggressive neuroendocrine skin tumor. Here we addressed these issues by determining TERT promoter mutations, gene amplification, mRNA expression and association with clinical variables in MCC. TERT mRNA was expressed in 6/6 MCC cell lines and 41 of 43 tumors derived from 35 MCC patients. Telomerase activity was detectable in all 6 cell lines and 11 tumors analyzed. TERT promoter mutations were identified in 1/6 cell lines and 4/35 (11.4%) MCC cases. The mutation exhibited UV signature and occurred in sun-exposed areas. Increased TERT gene copy numbers were observed in 1/6 cell lines and 11/14 (79%) tumors, and highly correlated with its mRNA expression (r = 0.7419, P = 0.0024). Shorter overall survival was significantly associated with higher TERT mRNA levels in MCC patients (P = 0.032). Collectively, TERT expression and telomerase activity is widespread in MCC, and may be attributable to TERT promoter mutations and gene amplification. Higher TERT expression predicts poor patient outcomes.

[1]  C. Larsson,et al.  The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas , 2014, Oncogene.

[2]  M. Honavar,et al.  TERT promoter mutations in skin cancer: the effects of sun exposure and X-irradiation. , 2014, The Journal of investigative dermatology.

[3]  Dawei Xu,et al.  Special Topic: Stem Cells and Regenerative Medicine Telomerase as a " Stemness " Enzyme , 2022 .

[4]  M. Björkholm,et al.  The absence of TERT promoter mutations in primary gastric cancer. , 2014, Gene.

[5]  P. Rothberg,et al.  Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma , 2014, Modern Pathology.

[6]  C. Liu,et al.  TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas , 2014, Oncotarget.

[7]  J. Becker,et al.  Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma , 2014, Nature Communications.

[8]  K. Hemminki,et al.  TERT promoter mutations in cancer development. , 2014, Current opinion in genetics & development.

[9]  C. Larsson,et al.  MicroRNA Expression Patterns Related to Merkel Cell Polyomavirus Infection in Human Merkel Cell Carcinoma , 2013, The Journal of investigative dermatology.

[10]  D. Schadendorf,et al.  TERT Promoter Mutations Are Frequent in Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma , 2013, PloS one.

[11]  J. Yang,et al.  Telomerase reverse transcriptase promotes epithelial–mesenchymal transition and stem cell-like traits in cancer cells , 2013, Oncogene.

[12]  Miguel Melo,et al.  Frequency of TERT promoter mutations in human cancers , 2013, Nature Communications.

[13]  Gary L. Gallia,et al.  TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal , 2013, Proceedings of the National Academy of Sciences.

[14]  D. Schadendorf,et al.  TERT Promoter Mutations in Familial and Sporadic Melanoma , 2013, Science.

[15]  Lynda Chin,et al.  Highly Recurrent TERT Promoter Mutations in Human Melanoma , 2013, Science.

[16]  G. Roos,et al.  hTERT Cancer Risk Genotypes Are Associated With Telomere Length , 2012, Genetic epidemiology.

[17]  Trygve O Tollefsbol,et al.  Regulation of the human catalytic subunit of telomerase (hTERT). , 2012, Gene.

[18]  J. Becker,et al.  Merkel cell carcinoma: recent insights and new treatment options , 2012, Current opinion in oncology.

[19]  P. Moore,et al.  Merkel cell carcinoma: a virus-induced human cancer. , 2012, Annual review of pathology.

[20]  J. Shay,et al.  Role of telomeres and telomerase in cancer. , 2011, Seminars in cancer biology.

[21]  Jun-Ping Liu,et al.  Molecular regulation of telomerase activity in aging , 2011, Protein & Cell.

[22]  Y. Shin,et al.  Detection of Merkel cell polyomavirus in Merkel cell carcinomas and small cell carcinomas by PCR and immunohistochemistry. , 2011, Histology and histopathology.

[23]  S. Kuwamoto Recent advances in the biology of Merkel cell carcinoma. , 2011, Human pathology.

[24]  J. C. Becker,et al.  Merkel cell carcinoma. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  J. Pfeifer,et al.  Merkel Cell Polyomavirus: A Specific Marker for Merkel Cell Carcinoma in Histologically Similar Tumors , 2009, The American journal of surgical pathology.

[26]  L. Chin,et al.  Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma including amplification of L-Myc. , 2009, The Journal of investigative dermatology.

[27]  S. Kyo,et al.  Activation of telomerase by human cytomegalovirus. , 2009, Journal of the National Cancer Institute.

[28]  C. Harley,et al.  Telomerase and cancer therapeutics , 2008, Nature Reviews Cancer.

[29]  P. Moore,et al.  Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma , 2008, Science.

[30]  M. Bellon,et al.  Regulation of telomerase and telomeres: human tumor viruses take control. , 2008, Journal of the National Cancer Institute.

[31]  H. Sandler,et al.  Merkel cell carcinoma: Critical review with guidelines for multidisciplinary management , 2007, Cancer.

[32]  P. Boukamp,et al.  Telomeres rather than telomerase a key target for anti‐cancer therapy? , 2007, Experimental dermatology.

[33]  Frank Speleman,et al.  Combined karyotyping, CGH and M‐FISH analysis allows detailed characterization of unidentified chromosomal rearrangements in Merkel cell carcinoma , 2002, International journal of cancer.

[34]  J. Shay,et al.  Human Telomerase and Its Regulation , 2002, Microbiology and Molecular Biology Reviews.

[35]  A. Zetterberg,et al.  Amplification of the telomerase reverse transcriptase (hTERT) gene in cervical carcinomas , 2002, Genes, chromosomes & cancer.

[36]  S. Jhanwar,et al.  SV40 infection induces telomerase activity in human mesothelial cells , 2002, Oncogene.

[37]  R. Moll,et al.  Telomerase activity of Merkel cell carcinomas and Merkel cell carcinoma-derived cell cultures , 2001, Archives of Dermatological Research.

[38]  A. Zetterberg,et al.  Frequent amplification of the telomerase reverse transcriptase gene in human tumors. , 2000, Cancer research.